TISSUE-PLASMINOGEN ACTIVATOR ACTIVITY IN HUMAN AQUEOUS-HUMOR

被引:0
|
作者
SMALLEY, DM [1 ]
FITZGERALD, JE [1 ]
TAYLOR, DM [1 ]
CONE, RE [1 ]
OROURKE, J [1 ]
机构
[1] UNIV CONNECTICUT,SCH MED,DEPT PATHOL,FARMINGTON,CT 06030
关键词
TISSUE PLASMINOGEN ACTIVATOR; AQUEOUS HUMOR; UROKINASE; PROTEASE;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To determine the levels of free plasminogen activator activity in human aqueous humor and to identify the type of activity (i.e., tissue-type t-PA or urokinase-type u-PA) that is responsible. Methods. Aqueous humor was obtained by a simplified pipette paracentesis before cataract surgery in 31 subjects, ages 57 to 93 years. Levels of plasminogen activator activity were determined using a modified 17-hour specific amidolytic assay. The type of plasminogen activator was investigated in selected samples based on its dependence on soluble fibrin, inhibition by amiloride, and specific antibody blocking. Activity-antigen ratios were compared in seven samples. Results. Plasminogen activator (PA) activity was present in all samples tested. PA activity ranged widely between 0.54 and 26.7 mIU/ml, with a mean value of 10.8 +/- 8.1 mIU/ml. Soluble fibrin, a known stimulator of tissue-type plasminogen activator (t-PA), was required in the assay system. Its absence decreased the measured activity by more than 90%. Amiloride, a known inhibitor of urokinase-type PA, had little or no effect in selected samples tested. The activity was blocked by anti-human t-PA antibodies but not by antibodies against human u-PA, further defining the type of PA responsible for the detected activity. t-PA antigen levels showed less variation among individuals than did activity levels. Antigen-activity ratios ranged between 89 and 552. Conclusion. Plasminogen activator activity is present in the human aqueous humor in measurable quantities. The type of PA activity present is almost exclusively t-PA. t-PA activity varies more widely than antigen, as is the case in plasma.
引用
收藏
页码:48 / 53
页数:6
相关论文
共 50 条
  • [21] Tissue-plasminogen activator for acute ischaemic stroke
    Ellis, SJ
    LANCET, 1997, 349 (9050): : 504 - 504
  • [22] FIBRINOLYTIC THERAPY USING TISSUE-PLASMINOGEN ACTIVATOR
    VANDER, JF
    CURRENT OPINION IN OPHTHALMOLOGY, 1993, 4 (03) : 56 - 61
  • [23] PHYSICAL CHARACTERIZATION OF RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR
    MARGOSSIAN, SS
    SLAYTER, HS
    KACZMAREK, E
    MCDONAGH, J
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1163 (03) : 250 - 256
  • [24] LYSOSOMAL-ENZYME ACTIVITY IN HUMAN AQUEOUS-HUMOR
    WEINREB, RN
    JENG, SY
    MILLER, AL
    CLINICA CHIMICA ACTA, 1991, 199 (01) : 1 - 6
  • [25] ASSIGNMENT OF THE BINDING-SITE FOR TISSUE-PLASMINOGEN ACTIVATOR ON HUMAN FIBRONECTIN
    WANG, L
    LIN, XH
    CUI, DF
    WANG, ZY
    CHI, CW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (06) : 4332 - 4336
  • [26] THE USE OF TISSUE-PLASMINOGEN ACTIVATOR IN POSTVITRECTOMY CASES
    KOUTSANDREA, C
    APOSTOLOPOULOS, M
    THEODOSSIADIS, P
    INTERNATIONAL OPHTHALMOLOGY, 1993, 17 (02) : 95 - 100
  • [27] TISSUE-PLASMINOGEN ACTIVATOR (T-PA)
    MADHANI, J
    MOVSOWITZ, H
    KOTLER, MN
    THERAPEUTIC DRUG MONITORING, 1993, 15 (06) : 546 - 551
  • [28] INCREASING THE FIBRIN SPECIFICITY OF TISSUE-PLASMINOGEN ACTIVATOR
    CHOW, AM
    PENA, LC
    KEYT, BA
    ZOLLER, MJ
    BENNETT, WF
    PAONI, NF
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 762 - 762
  • [29] THROMBOLYTIC THERAPY WITH TISSUE-PLASMINOGEN ACTIVATOR IN NEONATES
    HO, CK
    DANNAWI, H
    HAM, WL
    CONNER, ED
    CLINICAL RESEARCH, 1993, 41 (04): : A814 - A814
  • [30] TREATMENT OF INTRAVENTRICULAR HEMORRHAGE WITH TISSUE-PLASMINOGEN ACTIVATOR
    FINDLAY, JM
    GRACE, MGA
    WEIR, BKA
    HAINES, SJ
    SAWAYA, R
    NEUROSURGERY, 1993, 32 (06) : 941 - 947